Current Studies

Development of a Quality of Life Questionnaire for patients with Metastatic Breast Cancer

Online symptom monitoring and tailored advice for patients with metastatic breast cancer on combination endocrine and targeted treatments

Revision of the EORTC QLQ-BN20 brain tumour module

Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours

A pilot study of a smartphone-based symptom assessment application (OurBrainBank) for people diagnosed with glioblastoma multiforme

Understanding the long-term implications of treatment of rare brain tumours on health-related quality of life: a European cross-sectional study

Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma

Support Needs of Young Brain Tumour Survivors and their Caregivers

Closed Studies

• DECIDE: Dementia Carers Instrument Development
• Curative treatment modalities of early stages Non-Small Cell Lung Cancer: Effect on Patient Reported Outcomes of Video Assisted Thoracoscopic (VATS) Resection and Stereotactic Ablative Body Radiotherapy (LILAC)
• Optimising Individual Treatment Regimes and Patient Outcomes through the Use of Patient-Reported Toxicity Assessments in Patients treated with Pelvic Radiotherapy (OPTIMAL)
• Reviewing items for self-report of adverse events in clinical trials (REPORT-UK)
• electronic Patient-reported Outcomes from Cancer Survivors (ePOCS): A feasibility study
• Allinex: Using Technology to Improve Clinical Care
• QuEST T2: Pilot Study of Doctor Training Programme
• Evaluating the needs of patients living with chronic cancer: interviews and survey development
• Attention Control
• EORTC Quality of Life Group
• Social Impact of Cancer
• Compass
• Assessment of routine practice in outpatient oncology
• Questionnaire Validation
• Breast Cancer Campaign Study
• Using the internet for information exchange: design and evaluation of a website for use in follow up of cancer patients at low risk of recurrence
• Quality of Life Metric